Is the Scarbossa criteria (Scarbossa's criteria) the current standard practice for diagnosing pulmonary embolism (PE)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 23, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

The Scarbossa criteria are not the current standard practice for diagnosing pulmonary embolism (PE). Instead, the diagnosis of PE is typically made using a combination of clinical evaluation, plasma D-dimer measurement, lower limb venous compression ultrasonography, and imaging studies such as computed tomography pulmonary angiography (CTPA) or ventilation-perfusion scans, as recommended by the American College of Physicians and the European Society of Cardiology 1. The use of validated clinical prediction rules, such as the Wells score or the Geneva score, is also recommended to estimate pretest probability in patients with suspected PE 1. The Scarbossa criteria are actually used to diagnose acute myocardial infarction in patients with left bundle branch block (LBBB) on electrocardiogram (ECG), not PE. Key findings in the diagnosis of PE include:

  • Clinical presentation, such as symptoms and risk factors
  • Plasma D-dimer measurement
  • Imaging studies, such as CTPA or ventilation-perfusion scans
  • Clinical prediction rules, such as the Wells score or the Geneva score It is essential to note that the diagnosis of PE requires a comprehensive approach, taking into account the patient's clinical presentation, medical history, and the results of diagnostic tests. The American College of Physicians recommends using validated clinical prediction rules to estimate pretest probability in patients with suspected PE and obtaining imaging with CTPA in patients with high pretest probability of PE 1. In patients with low or intermediate pretest probability of PE, a high-sensitivity D-dimer measurement can be used as the initial diagnostic test, and imaging studies can be reserved for patients with a positive D-dimer result or those who do not meet all Pulmonary Embolism Rule-Out Criteria 1. Overall, the diagnosis of PE requires a careful and systematic approach, using a combination of clinical evaluation, laboratory tests, and imaging studies to ensure accurate diagnosis and effective treatment.

From the Research

Diagnosis of Pulmonary Embolism

There are no research papers provided to assist in answering the question of whether the Scarbossa criteria is the current standard practice for diagnosing pulmonary embolism (PE).

Available Studies

The provided studies focus on the diagnosis of acute appendicitis, discussing various criteria and methods such as the Alvarado score, C-reactive protein (CRP) measurements, ultrasound, and the neutrophil-lymphocyte ratio. These studies do not address pulmonary embolism or the Scarbossa criteria 2, 3, 4, 5, 6.

Relevance to Pulmonary Embolism

None of the studies directly relate to the diagnosis of pulmonary embolism or the use of the Scarbossa criteria in clinical practice. The Scarbossa criteria are not mentioned in any of the provided studies.

Conclusion Not Applicable

As there is no relevant information provided regarding the Scarbossa criteria or the diagnosis of pulmonary embolism, no further analysis can be conducted.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.